Free Trial
NASDAQ:JAN

JanOne (JAN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
$1.90
$4.01
52-Week Range
N/A
Volume
139,500 shs
Average Volume
229,417 shs
Market Capitalization
$20.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
JAN stock logo

About JanOne Stock (NASDAQ:JAN)

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through Biotechnology and Recycling segments. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.

JAN Stock News Headlines

Dave Ramsey Makes Big Mistake Live On Air
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
Prepare for a Recession Unlike Any Other
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
JAN Stock Earnings: JanOne Reported Results for Q1 2024
See More Headlines
Receive JAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for JanOne and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/03/2024
Today
7/26/2024
Next Earnings (Estimated)
8/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:JAN
Employees
170
Year Founded
N/A

Profitability

Net Income
$-7,810,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$39.61 million
Book Value
($0.67) per share

Miscellaneous

Free Float
8,707,000
Market Cap
$20.03 million
Optionable
Not Optionable
Beta
2.16
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives


JAN Stock Analysis - Frequently Asked Questions

How were JanOne's earnings last quarter?

JanOne Inc. (NASDAQ:JAN) released its quarterly earnings results on Friday, May, 3rd. The company reported ($0.34) EPS for the quarter.

How do I buy shares of JanOne?

Shares of JAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:JAN) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners